恩华药业：上半年净利润7亿元 同比增11.38%

Group 1 - The company reported a revenue of 3.01 billion yuan for the first half of 2025, representing a year-on-year growth of 8.93% [1] - The net profit attributable to shareholders reached 700 million yuan, with a year-on-year increase of 11.38% [1] - The basic earnings per share stood at 0.69 yuan [1]